As of November 7, 2026, Xeris Biopharma Holdings, Inc. is a publicly traded company (Nasdaq: XERS). The largest insider holding is Shannon John Patrick Jr, a director, with 2,898,933 shares (1.6% of shares outstanding), per Form 4 of August 21, 2026. No bankruptcy or receivership appears in its SEC Form 8-K filings (Schedule 13G, July 31, 2026).
Is this your company?
About to sign with, pay or invest in Xeris Biopharma Holdings Inc? See the free Snapshot first.
Free to see. No signup.
Is Xeris Biopharma Holdings, Inc. a real, registered company?
- Xeris Biopharma Holdings Inc files with the SEC under CIK 1867096 (its SEC filings).
- Its shares are listed under the ticker XERS on Nasdaq (SEC company record).
- business address in Chicago, Illinois, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Xeris Biopharma Holdings Inc in our court records and SEC 8-K records (as of 2026-11-07).
- Leadership changes: the latest reported is Menassie Taddese (Form 8-K filed 2026-11-02). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Vanguard (filed 2026-07-31).
Who are Xeris Biopharma Holdings, Inc.'s owners and officers?
Xeris Biopharma Holdings, Inc.: business address in Chicago, Illinois; industry Pharmaceutical Preparations (Form D, 2026-11-02).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-10-30 | Vanguard Capital Management | 4.98% |
| Schedule 13G, 2026-07-31 | Vanguard Capital Management | 5% |
| Schedule 13G/A, 2026-03-27 | The Vanguard Group | 0% |
| Schedule 13G/A, 2026-01-30 | The Vanguard Group | 6.74% |
Want the whole picture on Xeris Biopharma Holdings Inc?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Xeris Biopharma Holdings Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Xeris Biopharma Holdings Inc covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
13 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-11-02 | Menassie Taddese | appointed | 2026-11-02 | |
| Form 8-K, 2026-06-30 | Nerissa Kreher | appointed | 2026-07-01 | |
| Form 8-K, 2026-06-30 | Nerissa Kreher | Director | appointed | |
| Form 8-K, 2026-04-21 | Jeffrey Sherman | Director | departed |
Which insiders own Xeris Biopharma Holdings, Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , a director: 2,898,933 shares (1.6% of shares outstanding) (Form 4, 2026-08-21).
- Kevin McCulloch: 1,584,208 shares (0.87% of shares outstanding), 1,559,208 held directly and 25,000 indirectly (Form 4, 2026-11-06).
- Steven Pieper: 1,346,053 shares (0.74% of shares outstanding) (Form 4, 2026-11-04).
- Beth Hecht: 1,086,130 shares (0.59% of shares outstanding) (Form 4, 2026-11-04).
- , a director: 707,276 shares (0.39% of shares outstanding) (Form 4, 2026-06-05).
Shares outstanding: 182,700,038 as of 2026-10-31, from the company's latest SEC cover page.
How much has Xeris Biopharma Holdings, Inc. raised?
No fundraising or offering filing from Xeris Biopharma Holdings, Inc. is on file with us.
Keep reading
More on Xeris Biopharma Holdings Inc and the records around it.
Xeris Biopharma Holdings Inc elsewhere on the record
- Leadership changes Jun 2026
Companies that share a holder
- Vanguard Capital Management also filed stake reports on 1495 other companies: A10 Networks Inc (Oct 2026), Altisource Portfolio Solutions SA (Oct 2026), Alto Neuroscience Inc (Oct 2026)
- The Vanguard Group also filed stake reports on 2384 other companies: BellRing Brands, Inc. (Sep 2026), CAL-MAINE FOODS INC (Sep 2026), FTAI Aviation Ltd. (Sep 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/xeris-biopharma